GlobeNewswire Inc | Aug 27, 2020 05:00AM EDT

August 27, 2020

BEIJING, Aug. 27, 2020 (GLOBE NEWSWIRE) -- So-Young International Inc. (Nasdaq: SY) (So-Young or the Company), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial results for the three months ended June30, 2020.

Second Quarter 2020 Financial Highlights

-- Total revenues were RMB328.2 million (US$46.5 million1), an increase of 15.2% from RMB285.0 million in the same period of 2019, in line with our previous guidance. -- Net income was RMB2.1 million (US$0.3 million), compared with a net income RMB29.3 million in the same period of 2019. -- Non-GAAP net income2 was RMB30.1 million (US$4.3 million), compared with a non-GAAP net income of RMB102.2 million in the same period of 2019.

Second Quarter 2020 Operational Highlights

-- Average mobile MAUs were 6.8 million, an increase of 173.7% from 2.5 million in the second quarter of 2019. -- Total number of users purchasing reservation service were 170,553 and the aggregate value of medical aesthetic treatment transactions facilitated by So-Youngs platform was RMB939.6 million. -- Number of paying medical service providers on So-Youngs platform were 3,735, an increase of 18.3% from 3,157 in the second quarter of 2019.

Recent Updates

-- In May, So-Young launched the So-Young Charity Fund and the first phase sized up to RMB10 million in total. Together with the China Plastic and Aesthetic Association, the Company continued to provide support for doctors, information, funds, education, psychological counseling among other support for people who have been injured by medical accidents or congenital deformities.

Mr. Xing Jin, Co-Founder and Chief Executive Officer of So-Young, commented, Despite ongoing weaker-than-normal consumer sentiment and restrictions on general mobility in parts of China as a result of the outbreak of COVID-19, we made significant progress in expanding our vibrant community of users and medical aesthetic professionals and driving traffic through our platform. We grew our community to an average of mobile MAUs of 6.8 million, an increase of 173.7% year-over-year from 2.5 million during the same period of 2019.

Mr. Jin added, We focused on two core initiatives to drive our user growth and engagement during the quarter. First, we made great progress in increasing the trust between users and our platform by rolling out the preferred doctor lists, what we call Emerald Doctor Lists. Second, we expanded our community of users and medical aesthetic professionals through consistent content upgrades, including optimizing our live video diagnosis service and launching the So-Young Ambassador project, which generated a warm response within our community. Looking ahead, as our platform continues to provide an open, diversified and trustworthy ecosystem for our users and medical aesthetic professionals, we firmly believe that we can further increase our market share in the medical aesthetics industry over the long term.

We continued to focus our resources on enhancing our communitys stickiness and elevating the So-Young brand to expand our addressable market, commented Mr. Min Yu, Chief Financial Officer of So-Young. In terms of commercialization, we officially launched a membership service for small-to-medium service providers during the quarter. Combined with our existing services and aligned operations, we are confident that we will be able to maintain our healthy growth momentum and generate long-term value for our shareholders.

Second Quarter 2020 Financial Results

Revenues

Total revenues were RMB328.2 million (US$46.5 million), an increase of 15.2% from RMB285.0 million in the same period of 2019. The increase was primarily due to increases in number of paying medical service providers which gradually recovered operation after the COVID-19 pandemic becomes better controlled in China.

-- Information servicesrevenues were RMB234.5 million (US$33.2 million), an increase of 10.6% from RMB212.0 million in the same period of 2019. The increase was mainly due to increases in average revenue per medical service provider. Total number of medical service providers subscribing to information services on So-Youngs platform were 2,056. -- Reservation servicesrevenues were RMB93.7 million (US$13.3 million), an increase of 28.4% from RMB73.0 million in the same period of 2019. The increase was primarily due to successful conducting the 6.6 Shopping Festival in June, which captured most users with interests in medical aesthetic consumption.

Costs of Revenues

Costs of revenues were RMB50.7 million (US$7.2 million), an increase of 1.9% from RMB49.8 million in the second quarter of 2019. Cost of revenues included share-based compensation expenses of RMB6.0 million (US$0.8 million) during the second quarter of 2020, compared with RMB6.8 million in the corresponding period of 2019.

Operating Expenses

Total operating expenses were RMB287.4 million (US$40.7 million), an increase of 27.8% from RMB224.8 million in the second quarter of 2019.

-- Sales and marketingexpenses were RMB185.2 million (US$26.2 million), an increase of 75.0% from RMB105.8 million in the second quarter of 2019. The increase was primarily due toan increase in expenses associated with marketing campaigns and user acquisition initiatives. Sales and marketing expenses for the second quarter of 2020 included share-based compensation expenses of RMB1.6 million (US$0.2 million), compared with RMB4.5 million in the corresponding period of 2019. -- General and administrativeexpenses were RMB49.8 million (US$7.1 million), a decrease of 25.9% from RMB67.3 million in the second quarter of 2019. General and administrative expenses for the second quarter of 2020 included share-based compensation expenses of RMB14.2 million (US$2.0 million), compared with RMB45.4 million in the corresponding period of 2019. The decrease in share-based compensation expenses was primarily due to recognition of share-based compensation expenses during the second quarter of 2019 related to historical employee options granted, which were contingent upon the completion of the Companys initial public offering. -- Research and developmentexpenses were RMB52.3 million (US$7.4 million), an increase of 1.3% from RMB51.7 million in the second quarter of 2019. The increase was primarily a result of costs associated with increased hiring to support product development, which is in line with the Companys strategy of strengthening its technology and big data analysis capabilities. Research and development expenses for the second quarter of 2020 included share-based compensation expenses of RMB6.2 million (US$0.9 million), compared with RMB16.1 million in the corresponding period of 2019.

Income Tax Expenses

Income tax expense was RMB2.8 million (US$0.4 million), compared with a RMB10.8 million income tax expense in the same period of 2019, primarily due to the decrease in taxable income during the second quarter of 2020.

Net income

Net income was RMB2.1 million (US$0.3 million), compared with a net income RMB29.3 million in the second quarter of 2019.

Non-GAAP net income

Non-GAAP net income, which excludes the impact of share-based compensation expenses was RMB30.1 million (US$4.3 million), compared with RMB102.2 million non-GAAP net income in the same period of 2019.

Basic and Diluted Earnings per ADS

Basic and diluted income per ADS attributable to ordinary shareholders were RMB0.02 (US$0.00) and RMB0.02 (US$0.00), compared with basic and diluted earnings per ADS attributable to ordinary shareholders of RMB0.22 and RMB0.21 in the same period of 2019.

Cash and Cash Equivalents, Restricted Cash and Term Deposits and Short-Term Investments

As of June30, 2020, the Company had cash and cash equivalents, restricted cash and term deposits and short-term investments of RMB2,883.2 million (US$408.1 million), compared with RMB2,844.0million as of December31, 2019. The increase was primarily due to the cash generated from operating activities during the second quarter.

Business Outlook

For the third quarter of 2020, So-Young expects total revenues to be between RMB340 million (US$48.1 million) and RMB370 million (US$52.4 million), representing a 12.4% to 22.3% increase from the same period in 2019. The above outlook is based on the current market conditions and reflects the Companys preliminary estimates of market and operating conditions, and customer demand, particularly in view of the potential impact of the COVID-19, the effects of which are difficult to analyze and predict, which are all subject to change.

Non-GAAP Financial Measures

To supplement the financial measures prepared in accordance with generally accepted accounting principles in the United States, or GAAP, this press release presents non-GAAP income from operations and non-GAAP net income by excluding share-based compensation expenses from income from operations and net income, respectively. The Company believes these non-GAAP financial measures are important to help investors understand the Companys operating and financial performance, compare business trends among different reporting periods on a consistent basis and assess the Companys core operating results, as they exclude certain expenses that are not expected to result in cash payments. The use of the above non-GAAP financial measures has certain limitations. Share-based compensation expenses have been and will continue to be incurred in the future and are not reflected in the presentation of the non-GAAP financial measures, but should be considered in the overall evaluation of the Companys results. The Company compensates for these limitations by providing the relevant disclosure of its share-based compensation expenses in the reconciliations to the most directly comparable GAAP financial measures, which should be considered when evaluating the Companys performance. These non-GAAP financial measures should be considered in addition to financial measures prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measure is set forth at the end of this release.

Conference Call InformationSo-Youngs management will hold an earnings conference call on Thursday, August 27, 2020, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Participants can register for the conference call by navigating to http://apac.directeventreg.com/registration/event/1179314.

Once preregistration has been completed, participants will receive dial-in numbers, an event passcode, and a unique registrant ID.

To join the conference, please dial the number you receive, enter the event passcode followed by your unique registrant ID, and you will be joined to the conference instantly.

A telephone replay will be available two hours after the conclusion of the conference call through 9:59 AM U.S. Eastern Time, September 4, 2020. The dial-in details are:

International: +61-2-8199-0299US: +1-646-254-3697Passcode: 1179314

Additionally, a live and archived webcast of this conference call will be available at http://ir.soyoung.com.

About So-Young International Inc.So-Young International Inc. (Nasdaq: SY) (So-Young or the Company) is the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry. The Company presents users with reliable information through offering high quality and trustworthy content together with a multitude of social functions on its platform, as well as by curating medical aesthetic service providers that are carefully selected and vetted. Leveraging So-Youngs strong brand image, extensive audience reach, trust from its users, highly engaging social community and data insights, the Company is well-positioned to expand both along the medical aesthetic industry value chain and into the massive, fast-growing consumption healthcare service market.

Safe Harbor StatementThis announcement contains forward-looking statements. These statements are made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as will, expects, anticipates, future, intends, plans, believes, estimates, confident and similar statements. Among other things, the Financial Guidance and quotations from management in this announcement, as well as So-Youngs strategic and operational plans, contain forward-looking statements. So-Young may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about So-Youngs beliefs and expectations, are forward-looking statements. Forward looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: So-Youngs strategies; So-Youngs future business development, financial condition and results of operations; So-Youngs ability to retain and increase the number of users and medical service providers, and expand its service offerings; competition in the online medical aesthetic service industry; changes in So-Youngs revenues, costs or expenditures; Chinese governmental policies and regulations relating to the online medical aesthetic service industry, general economic and business conditions globally and in China; the impact of the COVID-19 pandemic to So-Youngs business operations and the economy in China and elsewhere generally; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Companys filings with the Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release, and So-Young undertakes no duty to update such information, except as required under applicable law.

For more information, please contact:

So-Young

Investor RelationsMs.Vivian XUPhone:+86-10-8790-2012E-mail: ir@soyoung.com

Christensen

In ChinaMr.Eric YuanPhone: +86-10-5900-1548E-mail: Eyuan@christensenir.com

In USMs.Linda BergkampPhone: +1-480-614-3004Email: lbergkamp@christensenir.com

As of December June 30, June 30, 31, 2020 2020 2019 RMB RMB US$ Assets Current assets: Cash and cash equivalents 884,676 1,574,120 222,802 Restricted cash 16,509 16,003 2,265 Trade receivables 26,110 39,288 5,561 Receivables from online payment 13,429 16,359 2,315 platformsAmounts due from related parties 5,815 10,573 1,497 Term deposits and short-term 1,942,860 1,293,093 183,025 investmentsPrepayment and other current assets 67,628 49,326 6,983 Total current assets 2,957,027 2,998,762 424,448 Non-current assets: Long-term investments 45,980 42,878 6,069 Intangible assets 726 42,289 5,986 Property and equipment, net 32,341 31,838 4,506 Deferred tax assets 35,208 37,708 5,337 Operating lease right-of-use assets 144,488 135,398 19,164 Other non-current assets 14,184 14,651 2,074 Total non-current assets 272,927 304,762 43,136 Total assets 3,229,954 3,303,524 467,584 Liabilities Current liabilities: Taxes payable 65,605 39,145 5,541 Contract liabilities 93,725 96,873 13,711 Salary and welfare payables 100,676 90,414 12,796 Amounts due to related parties 2,620 2,300 326 Accrued expenses and other current 166,088 226,159 32,012 liabilitiesOperating lease liabilities-current 37,799 44,276 6,267 Total current liabilities 466,513 499,167 70,653 Non-current liabilities: Operating lease liabilities-non 120,803 111,383 15,765 currentDeferred tax liabilities - 9,072 1,284 Total non-current liabilities 120,803 120,455 17,049 Total liabilities 587,316 619,622 87,702 Shareholders? equity: ClassA Ordinary shares (US$0.0005 parvalue;750,000,000 shares authorized as ofDecember31, 2019 and June 30, 2020; 221 224 32 69,371,718 and69,962,924 shares issued andoutstanding as of December31, 2019 andJune 30, 2020, respectively)ClassB Ordinary shares (US$0.0005 parvalue;20,000,000 shares authorized as ofDecember31, 2019 and June30, 2020; 37 37 5 12,000,000 shares issued andoutstanding as of December31, 2019 andJune 30, 2020)Additional paid-in capital 2,799,336 2,842,132 402,278 Statutory reserves 10,562 10,562 1,495 Accumulated deficit (259,251 ) (293,778 ) (41,582 ) Accumulated other comprehensive income 91,733 124,725 17,654 Total shareholders? equity 2,642,638 2,683,902 379,882 Total liabilities and shareholders? 3,229,954 3,303,524 467,584 equity

For the Three Months Ended For the Six Months Ended June 30, June 30, June 30, June 30, June 30, June 30, 2019 2020 2020 2019 2020 2020 RMB RMB US$ RMB RMB US$ Revenues Information 212,004 234,512 33,193 354,556 360,524 51,029 servicesReservation 72,981 93,708 13,264 136,482 150,250 21,267 servicesTotal revenues 284,985 328,220 46,457 491,038 510,774 72,296 Cost of (49,803 ) (50,744 ) (7,182 ) (86,220 ) (93,843 ) (13,283 ) revenuesGross profit 235,182 277,476 39,275 404,818 416,931 59,013 Operating expenses:Sales andmarketing (105,800 ) (185,182 ) (26,211 ) (181,298 ) (294,299 ) (41,655 ) expensesGeneral andadministrative (67,305 ) (49,849 ) (7,056 ) (92,133 ) (83,804 ) (11,862 ) expensesResearch anddevelopment (51,669 ) (52,325 ) (7,406 ) (83,014 ) (95,122 ) (13,464 ) expensesTotaloperating (224,774 ) (287,356 ) (40,673 ) (356,445 ) (473,225 ) (66,981 ) expensesIncome/(loss)from 10,408 (9,880 ) (1,398 ) 48,373 (56,294 ) (7,968 ) operationsOther income/ (expenses):Investment 1,192 2,814 398 3,472 5,789 819 incomeInterest 10,392 11,785 1,668 15,843 25,377 3,592 incomeExchange (4,278 ) (27 ) (4 ) 2,018 36 5 (losses)/gainsShare oflosses of - (1,395 ) (197 ) - (3,147 ) (445 ) equity methodinvesteeOthers, net 22,322 1,619 229 23,262 (7,026 ) (994 ) Income/(loss) 40,036 4,916 696 92,968 (35,265 ) (4,991 ) before taxIncome tax(expenses)/ (10,762 ) (2,776 ) (393 ) (17,789 ) 1,522 215 benefitNet income/ 29,274 2,140 303 75,179 (33,743 ) (4,776 ) (loss)Accretions ofconvertibleredeemablepreferred (12,880 ) - - (50,219 ) - - shares toredemptionvalueNet income/(loss)attributable 16,394 2,140 303 24,960 (33,743 ) (4,776 ) to ordinaryshareholdersof the Company

For the Three Months Ended For the Six Months Ended June 30, 2019 June 30, 2020 June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2020 RMB RMB US$ RMB RMB US$ Net income/(loss) per ordinary shareNet earnings/(loss) perordinary shareattributable 0.29 0.03 0.00 0.63 (0.42 ) (0.06 ) to ordinaryshareholder -basicNet earnings/(loss) perordinary shareattributable 0.27 0.03 0.00 0.57 (0.42 ) (0.06 ) to ordinaryshareholder -dilutedNet earnings/(loss) perADSattributableto ordinaryshareholders - 0.22 0.02 0.00 0.48 (0.32 ) (0.05 ) basic(13 ADSrepresents 10Class Aordinaryshares)Net earnings/(loss) perADSattributableto ordinaryshareholders - 0.21 0.02 0.00 0.44 (0.32 ) (0.05 ) diluted(13 ADSrepresents 10Class Aordinaryshares)Weightedaverage numberof ordinaryshares used incomputing 56,496,834 81,489,978 81,489,978 39,893,887 81,303,153 81,303,153 earnings/(loss) per share,basic*Weightedaverage numberof ordinaryshares used incomputing 60,744,127 83,677,136 83,677,136 43,703,139 81,303,153 81,303,153 earnings/(loss) per share,diluted* Share-basedcompensation expensesincluded in:Cost of (6,827 ) (5,986 ) (847 ) (7,109 ) (8,196 ) (1,160 ) revenuesSales andmarketing (4,527 ) (1,583 ) (224 ) (5,013 ) (2,303 ) (326 ) expensesGeneral andadministrative (45,424 ) (14,198 ) (2,010 ) (50,090 ) (22,535 ) (3,190 ) expensesResearch anddevelopment (16,144 ) (6,172 ) (874 ) (16,675 ) (9,167 ) (1,298 ) expenses

* Both Class A and Class B ordinary shares are included in the calculation of the weighted average number of ordinary shares outstanding, basic and diluted.

For the Three Months Ended For the Six Months Ended June June 30, June 30, June June 30, June 30, 30, 2020 2020 30, 2020 2020 2019 2019 RMB RMB US$ RMB RMB US$ GAAP income/(loss) from 10,408 (9,880 ) (1,398 ) 48,373 (56,294 ) (7,968 ) operationsAdd back:Shared-based 72,922 27,939 3,955 78,887 42,201 5,974 compensationexpensesNon-GAAPincome/ 83,330 18,059 2,557 127,260 (14,093 ) (1,994 ) (loss) fromoperations GAAP Netincome/ 29,274 2,140 303 75,179 (33,743 ) (4,776 ) (loss)Add back:Shared-based 72,922 27,939 3,955 78,887 42,201 5,974 compensationexpensesNon-GAAP net 102,196 30,079 4,258 154,066 8,458 1,198 income

__________________________________________________________________________________________________________________________________________________

1 This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are made at RMB 7.0651 to US$1.00, which was the U.S. dollars middle rate announced by the Board of Governors of the Federal Reserve System of the United States on June 30, 2020.

2 Non-GAAP net income is defined as net income excluding share-based compensation expenses. See Reconciliation of GAAP and Non-GAAP Results at the end of this press release.